Sep 2026
A mitochondria-targeted supramolecular nanoplatform overcomes cisplatin resistance via self-amplified ferroptosis.
This work presents a mitochondria-targeted, ROS-activatable supramolecular delivery nanoplatform for self-amplifying redox imbalance and reversing cisplatin resistance for enhanced cisplatin-based cancer therapy.
Ying Liu, Zong-Tao Zhou, Wei Ma et al.
· International journal of pha... · 0 citations